This Week in Psychedelics - 1.14.22

Cannabis

• Oregon State research shows hemp compounds prevent coronavirus from entering human cells (Oregon State University)

• Polls Funded By Marijuana Prohibitionist Group Show Big Support For Legalization Policies It Lobbies Against (Marijuana Moment)

• Top German Government Official Previews Marijuana Legalization Plan Details (Marijuana Moment)

• First-dose vaccinations quadruple in Quebec ahead of restrictions at liquor and cannabis stores (CTV News)

• Mississippi Senate Votes To Legalize Medical Marijuana, Defying Governor’s Veto Threat (Marijuana Moment)

• Oregon: New Rules Increase the Amount of Cannabis Adults Can Purchase Per Transaction (NORML)

• Ohio Marijuana Activists Turn In More Signatures For Legalization Initiative After Temporary Setback (Marijuana Moment)

• Delaware Lawmakers File New Marijuana Legalization Bill With Key Equity Revisions (Marijuana Moment)

• Kansas lawmaker wants to refer medical marijuana legalization to voters (Marijuana Business Daily)

• Austin Officials Certify Local Marijuana Decriminalization Initiative For May Ballot (Marijuana Moment)

• Wyoming Activists Prepare Cannabis Reform Initiatives (High Times)

• Virginia Lawmakers Divided On Releasing Marijuana Prisoners Following Legalization Taking Effect (Marijuana Moment)

• South Dakota Governor Wants Marijuana Activists To Pay Legal Bill For Her Lawsuit That Blocked Legalization (Marijuana Moment)

• Florida Marijuana Activists Pivot To 2024 For Legalization Ballot Initiative (Marijuana Moment)

Magic Mushrooms

• Global Coalition Launches Push To Reschedule Psilocybin Under International Rules (Marijuana Moment)

• Italian Officials Certify Signatures For National Marijuana And Psilocybin Referendum (Marijuana Moment)

• Rollups: The Emerging Magic Mushroom Monopoly (The American Prospect)

• Numinus Submits Clinical Trial Application for Phase 1 Trial on Proprietary Psilocybin Product (Psilocybin Alpha)

• Psilocybin Clinical Trial for Depression Launches at Pacific Neuroscience Institute (PR Newswire)

MDMA

• MAPS Publishes Open Science Approach to Synthesizing MDMA (Lucid News)

Ayahuasca

• A New Study Attempts To Quantify The Healing Powers Of Ayahuasca (Forbes)

Novel Psychoactive Substances

• Mydecine Achieves Innovative Supercomputing Artificial Intelligence Modeling in Psychedelic Drug Development Enabling Quick Screening of Billions of Compounds (Psilocybin Alpha)

• Field Trip Receives Notice of Allowance for US Patent Application Covering FT-104 (Isoprocin Glutarate), its Novel Psychedelic Molecule in Development (Psilocybin Alpha)

Ketamine

• Trial of Ketamine Therapy for Alcohol Use Disorder Reports Positive Findings (Technology Networks)

• Osmind Announces Publication of the Largest Real-World Analysis of Ketamine Infusion Therapy for Depression (Business Wire)

• Institutional Review Board Grants Approval for Cybin-Sponsored Feasibility Study Using Kernel Flow Technology to Measure Psychedelic Effects on the Brain (Psilocybin Alpha)

• Peter Thiel-Backed Psychedelics Company Gets FDA Approval To Study Ketamine Therapy (Forbes)

• PharmaTher Announces FDA Approval of Investigational New Drug (IND) Application for Ketamine to Treat ALS (Psilocybin Alpha)

Miscellaneous

• How Beer and Drugs Empowered an Ancient Andean Empire (Gizmodo)

• These States Could Legalize Marijuana Or Psychedelics In 2022 (Marijuana Moment)

• Virginia Could Decriminalize Psilocybin And Other Psychedelics With Newly Filed Bills (Marijuana Moment)

• Social Media Attacks and Ethical Issues in the Psychedelic Sector — Why can’t we all get on together for the greater good? (Medium)

• Missouri Patients Could Use Psychedelic Treatments Under New GOP ‘Right-To-Try’ Bill (Marijuana Moment)

• ‘Microdosers’ of LSD and magic mushrooms are wiser and more creative (Daily Maverick)

• Promising Psychedelic Therapy Legislation Set to Make Waves in 2022 (Psychedelic Spotlight)

• Vermont Lawmakers File Drug Decriminalization Bill With Hopes Of Promoting Harm Reduction (Marijuana Moment)

• Announcing a Major Healthy Persons Trial to Investigate the Brain Activity Effects of Psychedelic Medicines (Mind Medicine Australia)

• University Of Ottawa To Offer Psychedelic Studies Master’s Program Beginning In Fall 2022 (Healing Maps)

• The Connection between Psychedelics and Christianity (The Institute for the Advancement of Psychedelic Christianity)

• Metaphysical Insight: Psychedelics, Noetic Experiences, and Spinoza’s God (Sam Woolfe)

• How to Come Out to Your Kids About Psychedelics (DoubleBlind)

• Psychedelics in Healthcare: The Psychedelic Pharmacists Association (Truffle Report)

• Can Western Medicine Include the Sacred in Psychedelic-Assisted Psychotherapy? (Lucid News)

• How To Vet Your Psychedelic Guide (DoubleBlind)

• Mydecine to Launch Special Access Support and Supply Program in Canada Expanding Access to Psychedelic-Assisted Psychotherapy For Patients (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 8.28.20

Cannabis

• House To Vote On Historic Marijuana Legalization Bill Next Month, Leadership Announces (Marijuana Moment)

• Minnesota Tribe Just Legalized Medical Cannabis on Largest Reservation in State (MERRY JANE)

• Most Legal Marijuana States Had Fewer Vaping-Related Lung Injuries, Study Finds (Marijuana Moment)

• Michigan Tribe Is About to Create Its Own Legal Weed Market Free From State Control (MERRY JANE)

• Nebraska Medical Marijuana Initiative Heads To Ballot After Secretary Of State Rejects Challenge (Marijuana Moment)

• Washington Prankster Changed Green Traffic Light to Flash Image of a Pot Leaf (MERRY JANE)

• Pennsylvania governor calls for marijuana legalization to boost economic recovery (Leafly)

• Youth Marijuana Use Stable Amid Legalization’s Expansion, Feds Report (Marijuana Moment)

• The Fight for Medical Marijuana in Brazil (Chacruna)

• Study: Cannabis Associated with Increased Cessation of IV Opioid Use (NORML)

• Canada Will Officially Stop Drug Testing Student-Athletes for Weed (MERRY JANE)

• Elephant Will Be Given CBD To Treat Stress After Death Of Companion, Zoo Says (Marijuana Moment)

• Study: Medical Cannabis Use by Seniors Associated with Improved Quality of Life (NORML)

• Cannabis research database shows how U.S. funding focuses on harms of the drug (Science Magazine)

LSD

• LSD microdose trial for acute pain relief reports “remarkable” results (New Atlas)

• When Blind Melon frontman Shannon Hoon took LSD and delivered a monster performance at Woodstock (Far Out)

Magic Mushrooms

• Cultivating P. cubensis: Light and Tryptamine Are Key for Controlling Psilocybin and Psilocin Levels (Psychedelic Science Review)

• Ehave, Inc. Announces Psychedelic Retreats Through Its Mycotopia Therapy Subsidiary (Psilocybin Alpha)

MDMA

• Risky Sex and the Recreational Use of MDMA (Psychedelic Science Review)

• ATAI Life Sciences launches EmpathBio to treat post-traumatic stress disorder with novel MDMA product (Psilocybin Alpha)

Ayahuasca

• Are You Drinking Ayahuasca For the Wrong Reason? (Lucid News)

• Microdosing Ayahuasca: Common Dosage Explained (Reality Sandwich)

• Plantdemic: Tales of being Stranded Abroad (Reality Sandwich)

5-MeO-DMT

• 5-MeO-DMT: The Story Behind the “God Molecule” (DoubleBlind)

Salvia Divinorum

• Does Salvia Divinorum Have Therapeutic Potential? (Psychedelics Today)

Ketamine

• Colorado’s Health Department Forming Committee To Review Use Of Ketamine By First Responders (CBS Denver)

• Champignon to Begin Offering Esketamine Treatment for Adults With Major Depressive Disorder at the Canadian Rapid Treatment Centre of Excellence (Psilocybin Alpha)

• Ketamine Therapy Has Made Its Way On to Instagram (VICE)

• How Ketamine is Made: Everything You Need to Know (Reality Sandwich)

Miscellaneous

• Canadian Government Will Respond To Psychedelics Decriminalization Petition (Marijuana Moment)

• Decriminalize Nature DC shows that the psychedelic movement’s only real enemy is itself (New Amsterdam Psychedelic Law)

• Field Trip Psychedelics Inches Closes to Going Public: Definitive Amalgamation Agreement Reached (Psilobybin Alpha)

• Microdosing: Set and Setting (The Third Wave)

• Psychedelic Organizations Make Efforts to Address Racism (Lucid News)

• Psychedelics & Functional Mushroom Co Silo Wellness Inches Closer to Go-Public (Psilocybin Alpha)

• To maintain momentum, the Psychedelic Renaissance must go mainstream. (Psychedelic Frontier)

• Osmind pitches clinical management and data analysis for mental health practices using psychedelics (TechCrunch)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 5.29.20

Cannabis

• Supreme Court Declines Case On Marijuana Decriminalization Measures Blocked From Local Ballots (Marijuana Moment)

• Oklahoma: Governor Vetoes Measure Expanding Medical Cannabis Access, Reducing Possession Penalties (NORML)

• Man Serving 18 Years On Marijuana Charges Just Died In Federal Prison COVID-19 Outbreak (HuffPost)

• THC-Infused Semen Can Be A Side Effect Of Frequent Marijuana Use, Study Finds (Marijuana Moment)

• Louisiana: Senate Passes Amended Bill Permitting Doctors to Recommend Medical Cannabis for “Any Condition” (NORML)

• Medical Cannabis Trial in the UK Becomes First to Recruit Baby (The Cannabis Exchange)

• Scientists And Veterans File Lawsuit Challenging DEA’s Marijuana Rescheduling Denials (Marijuana Moment)

• Scientific Review Concludes That Cannabis Consumers Are at No Greater Risk of Occupational Injuries (NORML)

• Councillor says 'something stinks' over move to outlaw cannabis smell in West Nipissing (North Bay Nugget)

• Ancient shrine reveals how marijuana was used to evoke "religious ecstasy" (Inverse)

• Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients (NORML)

LSD

• Errol Morris Sets Timothy Leary LSD Doc at Showtime (Hollywood Reporter)

• Jefferson Airplane’s Grace Slick allegedly once plotted to spike President Nixon with LSD (Far Out Magazine)

Magic Mushrooms

• Signatures Submitted For Oregon Measure To Decriminalize Psilocybin (Oregon Public Broadcasting)

• Get Ready for Pharmaceutical-Grade Magic Mushroom Pills (VICE)

• Miami University Researchers Collaborate with PsyBio Therapeutics to Biosynthetically Produce Psilocybin, the Psychedelic Ingredient in Magic Mushrooms, and Other Psychoactive Drug Candidates to Treat Mental Health Challenges (Globe Newswire)

• New Wave Holdings Sponsors Non-Profit Coalition, Therapsil, to Launch a Medical Psilocybin Access Project for Canadians in Palliative Care (PR Newswire)

MDMA

• Inside MollyBabes, the Shady Porn Site That Exploited Women on Ecstasy (The Daily Beast)

• MindMed Adds MDMA to Develop Next-Gen Psychedelic Therapies (PR Newswire)

DMT

• New Study Shows How DMT Refreshes Perceptions (Lucid News)

Ayahuasca

• Survey on the Awareness of Sexual Abuse in Ayahuasca Settings (Chacruna)

• Supporting Grassroots Initiatives for Indigenous People in the Amazon during COVID (Chacruna)

Novel Psychoactive Substances

• The Complete Guide to 4-AcO-DMT: Synthetic Shrooms or in a Class of Its Own? (DoubleBlind)

• Solved: The Crystal Structure of N-Methyl-N-Propyltryptamine (MPT) (Psychedelic Science Review)

Nitrous Oxide

• Deadly new 'drug of choice' known as 'hippy crack' taking over Dublin as parents make shock discovery of bullet cylinders on ground (Dublin Live)

Ketamine

• New Study Backs Ketamine as Treatment Option for Depression (MD Magazine)

• Esketamine nasal spray may rapidly reduce depressive symptoms, suicidal ideation with intent (Healio)

PCP

• Artist warns of the dangers of the drug PCP, saying taking it as a student triggered terrifying breakdowns - including one manic episode where she plunged 30ft from a window (Daily Mail)

Miscellaneous

• Psilocybin Treatment And Drug Decrim Campaigns Submit Signatures To Qualify For Oregon Ballot (Marijuana Moment)

• New Study Categorizes All The Unexplainable Experiences Produced By Psychedelic Drugs (IFLScience)

• COVID-19 is costing drug cartels millions of dollars (NBC)

• Why Psychedelic Researchers Should Not Push Back Against Decriminalization (Chacruna)

• Mental Health Startup Osmind Helps Patients Seek Psychedelic Treatments (Psychedelic Times)

• Two New Releases Show Technology’s Psychedelic Frontier (Lucid News)

• Musings around Psychedelic Integration Therapy (Psychedelics Today)

• Native Tribes Should Have More Say in the Psychedelic Movement (DoubleBlind)

• Toronto's first psychedelic therapy clinic is open. We gave it a try (NOW Magazine)

• Dr. Gabor Maté, recognised physician and bestselling author, joins Numinus as Member of the Clinical Advisory Council (Numinus)

• Mice on Acid (Nautilus)

• Mystical Experience and Psychedelic-Assisted Psychotherapy: Insights from Guided-Imagery Therapy with Cancer Patients (Psychedelics Today)

• Novamind and Buzz Capital Announce Qualifying Transaction (Globe Newswire)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.